Pre-solicitationPosted May 19, 2026·Responses due Jun 9, 2026

FDA Occupational Safety, Industrial Hygiene, Information Systems, and Training (OSIST) IDIQ

FDA · FDA OFFICE OF ACQ GRANT SVCS

Stage
Early notice (sources sought, presolicitation or special notice)
NAICS
541690
Value
Not stated
Solicitation
OC-2026-132216
Set-aside
No Set aside used
PSC
R499
Place
Silver Spring, MD, USA
Contact
Sheneil Green (Sheneil.Green@fda.hhs.gov)
Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation OC-2026-132216 in this department, oldest first.

Early notice
  • May 19, 2026 · this notice
    Pre-solicitation
  • Jun 3, 2026
    Pre-solicitation
    Open
Solicitation
None posted
Award
  • Sep 16, 2026
    Award Notice
    IHRC, INCORPORATED · $14.5M
    Open

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Answer the notice: this is when the requirement can still be shaped.
  • Contact the contracting officer named on the notice.
  • Check who won similar work; they are the likely bidders.

What the notice says

Description The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS), intends to issue a competitive Full and Open solicitation for the award of a single-award Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract for Occupational Safety, Industrial Hygiene, Information Systems, and Training (OSIST) support services. The contemplated acquisition will be conducted in accordance with FAR Part 12, Acquisition of Commercial Products and Commercial Services; FAR Part 15, Contracting by Negotiation; and FAR Part 16.5, Indefinite-Delivery Contracts. The Governm… (show all)

ent intends to award one (1) IDIQ contract resulting from Solicitation No. 75F40126R00020. The resultant IDIQ contract is anticipated to support FDA enterprise-wide occupational safety, industrial hygiene, laboratory quality, biosafety, information systems, and training requirements through issuance of individual task orders. Task orders may be issued on a Firm-Fixed-Price (FFP), Time-and-Materials (T&M), Labor-Hour (LH), or hybrid basis. The anticipated ordering period is five (5) years from date of award. The anticipated maximum contract ceiling is $14,500,000. The guaranteed minimum will be satisfied through issuance of the initial task order at time of award. Services to be performed under the resultant IDIQ contract include, but are not limited to: Occupational safety and laboratory quality support services; Primary barrier equipment maintenance, repair, and certification; Industrial hygiene assessments and program support; Information and data systems support; Training development and management; Policy, compliance, and programmatic support services; BSL-3 laboratory re-verification and certification support; HVAC airflow and pressure differential testing; Vaporized hydrogen peroxide (VHP) decontamination services; and Biosafety compliance assessments aligned with CDC, NIH, USDA/APHIS, OSHA, ANSI, ISO, and related federal standards. Primary performance will occur at FDA Headquarters located at the White Oak Federal Research Center, 10903 New Hampshire Avenue, Silver Spring, Maryland 20993, with additional performance possible at FDA facilities nationwide. The Government is attaching a draft version of Solicitation No. 75F40126R00020 for industry review and planning purposes. The attached draft Request for Proposal (RFP) is provided to assist prospective offerors in understanding the anticipated scope and structure of the requirement and does not constitute the final solicitation. The draft solicitation is subject to change prior to formal issuance of the official solicitation on SAM.gov. This synopsis and attached draft solicitation are issued for informational and planning purposes only. The Government is not requesting proposals, capability statements, comments, questions, or responses at this time. No contract award will be made as a result of this notice. Any future solicitation will be separately posted to SAM.gov. The Government anticipates issuance of the formal solicitation on or about June 2026 via SAM.gov. Important Notice to Interested Offerors Offerors must be registered in the System for Award Management (SAM) at https://sam.gov at the time of proposal submission, prior to award, and throughout contract performance. This notice is issued solely for informational and planning purposes and does not constitute a solicitation. This synopsis shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. The Government will not reimburse respondents for any costs incurred in preparation of responses to this notice.

Who won similar work

23 award notices on SAM.gov in the last 24 months. Matched by: Same agency (FDA), any industry: a loose match.

Loose match: same agency, any industry. Read the titles before treating these as competitors.

Single-winner award sizes (23): middle half $401K to $21.4M, median $2.4M; range $82K to $120.8M.

WinnerAwardsValueLast
Please_See_Spreadsheet Silver Spring MD 20993 USA3$153.2MOct 8, 2026
DCT, INCORPORATED1$52.8MSep 15, 2026
TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC1$50.0MSep 16, 2025
NATI-NVE Support Services, LLC1$49.0MMay 21, 2026
HARVARD PILGRIM HEALTH CARE INC1$31.7MMar 30, 2026
TOXICOLOGIC PATHOLOGY ASSOCIATES INC1$26.1MSep 15, 2025
VITALANT Scottsdale AZ 85258 USA1$10.0MSep 8, 2025
WE PHARMA, INC.1$4.0MSep 11, 2026
THE BIONETICS CORP1$2.8MJul 21, 2025
ES SQUARED, LLC1$2.4MApr 13, 2026

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

Latest awards

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Food & Drug Administration (FDA) since 2024 (0 filings)
  • 0 of their lobbyists list a past Food & Drug Administration (FDA) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 129 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 0 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.